[Safety of plasma exchange therapy in patients with anti-NMDA receptor encephalitis].
To explore the safety of plasma exchange (PE) therapy in patients with anti-NMDA receptor encephalitis. Prospective reviews were conducted for the adverse events and therapeutic efficacies of PE therapy in 9 patients with anti-NMDA receptor encephalitis admitted into neuro-intensive care unit from January 2012 to January 2015. A total of 54 PE procedures were performed. The NMDA receptor antibody titer of cerebrospinal fluid (CSF) and/or sera in 9 patients (100%) decreased or turned negative. Five patients (55.5%) demonstrated clinical improvement after PE therapy. And clinical complications included frequent involuntary movements, hypotension, coagulation of PE channel, febricity, allergic response and errhysis around peripheral venous access. PE is effective, safe and well-tolerated in patients with anti-NMDA receptor encephalitis.